Mechanistic Study of NAT10 Deficiency Enhancing Olaparib Sensitivity in Triple Negative Breast Cancer by Inhibiting RAD51 ac4C Modification.(T0247-4.100)
Mechanistic Study of NAT10 Deficiency Enhancing Olaparib Sensitivity in Triple Negative Breast Cancer by Inhibiting RAD51 ac4C Modification.(T0247-4.100)
